Zeile, William L
McCune, Helen C
Musson, Donald G
O'Donnell, Brian
O'Neill, Charles A
Tsuruda, Laurie S
Zori, Roberto T
Laipis, Philip J
Article History
Received: 19 April 2017
Accepted: 30 November 2017
First Online: 31 January 2018
Competing interests
: Dr Laipis has no financial ties to BioMarin Pharmaceutical other than research funding. Dr Zori and McCune are consultants for BioMarin Pharmaceutical, and directed the Phase II and Phase III trials of rAvPAL-PEG in human patients carried out at the UF College of Medicine, also supported by BioMarin Pharmaceutical. They have no further conflicts of interest.